Bromfenac: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Bromfenac. Educational only — not medical advice.
Labeled uses
BromSite (bromfenac ophthalmic solution) 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
Source: FDA labeling via NIH DailyMed (set 144a5072…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.